共享决策干预指导剖宫产术后阿片类药物处方
本研究采用基于平板电脑的决策辅助工具开展共享决策会话,指导剖宫产术后阿片类药物处方。2016年4月11日至6月10日共筛选105名女性,75名符合条件,51名同意参与,1名因住院时间延长被排除。女性选择的5毫克羟考酮片中位数为20.0片(四分位距15.0-25.0),低于标准处方40片(P<.001)。结论认为共享决策方法使本队列术后阿片类药物处方量较本机构标准处方减少约50%。
要点
- 共享决策干预使剖宫产术后羟考酮处方中位数降至20.0片(四分位距15.0-25.0)。
- 该处方量显著低于本机构标准处方40片(P<.001)。
- 该方法有望减少剖宫产术后急性疼痛治疗后的剩余阿片类药物。
核心结论
- 共享决策方法指导剖宫产术后阿片类药物处方,使本队列术后阿片类药物处方数量较本机构标准处方减少约50%。
- 该方法有望减少剖宫产术后急性疼痛治疗后的剩余阿片类药物量。
研究设计与样本
- 本研究为基于平板电脑决策辅助工具的共享决策干预,用于指导剖宫产术后阿片类药物处方。
- 2016年4月11日至6月10日期间,共筛选105名女性,75名符合条件,51名同意参与,1名入组后因住院时间延长被排除。
- 女性首先接收关于剖宫产术后疼痛缓解典型轨迹和预期阿片类药物使用信息,然后选择5毫克羟考酮片处方数量,上限为本机构标准处方40片。
主要发现
- 女性选择的5毫克羟考酮片中位数处方量为20.0片(四分位距15.0-25.0)。
- 该中位数处方量低于标准40片处方(P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether a shared decision-making intervention decreases the quantity of oxycodone tablets prescribed after cesarean delivery. TECHNIQUE: A tablet computer-based decision aid formed the basis of a shared decision-making session to guide opioid prescribing after cesarean delivery. Women first received information on typical trajectories of pain resolution and expected opioid use after cesarean delivery and then chose the number of tablets of 5 mg oxycodone they would be prescribed up to the institutional standard prescription of 40 tablets. EXPERIENCE: From April 11, 2016, to June 10, 2016, 105 women were screened, 75 were eligible, and 51 consented to participate; one patient was excluded after enrollment as a result of prolonged hospitalization. The median number of tablets (5 mg oxycodone) women chose for their prescription was 20.0 (interquartile range 15.0-25.0), which was less than the standard 40-tablet prescription (P<.001). CONCLUSION: A shared decision-making approach to opioid prescribing after cesarean delivery was associated with approximately a 50% decrease in the number of opioids prescribed postoperatively in this cohort compared with our institutional standard prescription. This approach is a promising strategy to reduce the amount of leftover opioid medication after treatment of acute postcesarean pain. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02770612.
引用
- Prabhu M, McQuaid-Hanson E, Hopp S, et al. A Shared Decision-Making Intervention to Guide Opioid Prescribing After Cesarean Delivery. Obstet Gynecol. 2017. PMID: 28594762. doi:10.1097/AOG.0000000000002094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。